Lukas Biomedical Inc. (TPEX:6814)
Taiwan
· Delayed Price · Currency is TWD 27.20
+0.70 (2.64%)
Mar 10, 2026, 1:21 PM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 1.11 billion as of March 9, 2026. Its market cap has increased by 1.53% in one year.
Market Cap
1.11B
Enterprise Value
1.21B
Revenue
180.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.20
Market Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 1.11B, a decrease of -37.49%. That is a compound annual growth rate of -8.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.10B |
| Level Biotechnology | 1.10B |
| GeneReach Biotechnology | 1.17B |
| Enimmune | 1.27B |
| Taiwan Advance Bio-Pharmaceutical | 958.50M |
| TCI GENE | 949.86M |
| NatureWise Biotech & Medicals | 940.05M |
| Neith | 899.73M |